Delve into the field of miRNA with 7 promising companies with miRNA-focused candidates in the pipeline, from oncology to neurodegeneration.

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

As the signs point toward a potential Evotec acquisition, delve into what it could represent for the European biotech ...

Find out how Google DeepMind's AlphaFold3 platform could help scientists revolutionize the field of drug discovery.

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

Since Abcam's acquisition in 2023, founder Jonathan Milner has been making waves with his investment strategy. Discover his ...

After years of setbacks, biotechs are advancing treatments for Huntington’s disease, offering new hope as clinical studies ...

The hypoparathyroidism treatment space has made a buzz in 2024 with a major drug approval, acquisitions, and big advances in ...

Labiotech provides listing of 2025 biotech conferences and events purely as a service for readers. We are not responsible for any errors in dates or omissions. Please check event websites for further ...

A biotech startup’s journey to unicorn status hinges on its leadership and the culture fostered within the organization. A ...

Therapeutic strides in biotech are advancing promising candidates in clinic to address different stages of sleep apnea and ...